FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to phthisiourology, and can be used for diagnosing renal tuberculosis by ex juvantibus type 2 therapy. That is ensured by administering Perchlozone as an anti-tuberculosis preparation. Additionally, the renal region is exposed to radiation of an infrared laser with power 15 mWt for 10 minutes on each kidney alternating sides. Therapeutic course is two months. Before and after therapy, such symptoms as pain intensity by analogue scale in scores, number of daily urination, leukocyturia, haematuria are evaluated. If the above values are increased by 25 % or more, renal tuberculosis is diagnosed.
EFFECT: method provides sensitive specific high-performance diagnostics available for use both in hospital and in outpatient practice.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
DIFFERENTIAL DIAGNOSIS METHOD FOR DETERMINING TUBERCULOSIS AND NONSPECIFIC KIDNEY INFLAMMATION | 1999 |
|
RU2159440C1 |
METHOD OF DIAGNOSIS OF ACTIVE NEPHROPHTHISIS | 1997 |
|
RU2134056C1 |
DIFFERENTIAL DIAGNOSIS METHOD FOR DISTINGUISHING THE CASES OF NONSPECIFIC INFLAMMATION AND TUBERCULOSIS OF URINARY TRACT | 2005 |
|
RU2279075C1 |
METHOD OF TREATING UROGENITAL TUBERCULOSIS | 2019 |
|
RU2702655C1 |
METHOD FOR MICROCYST PREVENTION IN PATIENTS WITH CYSTIC TUBERCULOSIS | 2008 |
|
RU2372910C1 |
METHOD FOR DIAGNOSING KIDNEY TUBERCULOSIS | 1996 |
|
RU2121145C1 |
DIAGNOSTIC TECHNIQUE FOR FEMALE GENITAL TUBERCULOSIS IN STERILE WOMEN | 2013 |
|
RU2548765C1 |
METHOD OF DIAGNOSING LATENT TUBERCULOSIS OF EXTRAPULMONARY LOCALISATION | 2014 |
|
RU2571713C2 |
METHOD OF TREATING TUBERCULOUS SPASTIC MICROCYSTIS | 2013 |
|
RU2527905C1 |
METHOD FOR TREATING CAVERNOUS TUBERCULOSIS OF PROSTATE | 2018 |
|
RU2695601C1 |
Authors
Dates
2020-11-02—Published
2019-05-06—Filed